Literature DB >> 20224873

Successful unrelated donor cord blood transplantation for chronic granulomatous disease.

Tang-Her Jaing1, Wen I Lee, Po-Jen Cheng, Shih-Hsiang Chen, Jing-Long Huang, Yung-Kuei Soong.   

Abstract

This report exemplified a success of unrelated donor cord blood transplantation (CBT) in a 4-month-old boy with chronic granulomatous disease (CGD). Following Bu14/Cy200/ATG conditioning, the patient received an HLA 2-locus-mismatched cord blood unit, and the total number of infused nucleated cells was 11.52 x 10(7)/kg. Neutrophil engraftment was achieved on day +13, and a platelet count greater than 20 x 10(9)/L was achieved on day +50. The neutrophil oxidative burst was 100% normal with full donor lymphocyte reconstitution at 8 months post-transplant. This case highlights that unrelated donor CBT for CGD is potentially safe and feasible, even in early infancy, when an appropriately matched related or unrelated donor is unavailable.

Entities:  

Mesh:

Year:  2010        PMID: 20224873     DOI: 10.1007/s12185-010-0537-5

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  12 in total

1.  Advances in treatment for chronic granulomatous disease.

Authors:  Elizabeth M Kang; Harry L Malech
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

2.  Treatment of McLeod phenotype chronic granulomatous disease with reduced-intensity conditioning and unrelated-donor umbilical cord blood transplantation.

Authors:  Nobuhiro Suzuki; Naoki Hatakeyama; Masaki Yamamoto; Nobuo Mizue; Yuki Kuroiwa; Minami Yoda; Junko Takahashi; Yoshihiko Tani; Hiroyuki Tsutsumi
Journal:  Int J Hematol       Date:  2007-01       Impact factor: 2.490

3.  Mutations of chronic granulomatous disease in Turkish families.

Authors:  M Y Köker; O Sanal; M De Boer; I Tezcan; A Metin; F Ersoy; D Roos
Journal:  Eur J Clin Invest       Date:  2007-07       Impact factor: 4.686

4.  Transplantation of unrelated donor umbilical cord blood utilizing double-unit grafts for five teenagers with transfusion-dependent thalassemia.

Authors:  T-H Jaing; C-P Yang; I-J Hung; S-H Chen; C-F Sun; R Chow
Journal:  Bone Marrow Transplant       Date:  2007-06-18       Impact factor: 5.483

Review 5.  Gene therapy for chronic granulomatous disease.

Authors:  Cecilia N Barese; W Scott Goebel; Mary C Dinauer
Journal:  Expert Opin Biol Ther       Date:  2004-09       Impact factor: 4.388

Review 6.  Successful unrelated cord blood transplantation for chronic granulomatous disease: a case report and review of the literature.

Authors:  Kazuhiro Mochizuki; Atsushi Kikuta; Masaki Ito; Mitsuko Akaihata; Hideki Sano; Hitoshi Ohto; Mitsuaki Hosoya
Journal:  Pediatr Transplant       Date:  2008-07-09

Review 7.  Modern management of chronic granulomatous disease.

Authors:  Reinhard A Seger
Journal:  Br J Haematol       Date:  2008-02       Impact factor: 6.998

8.  Successful umbilical cord blood stem cell transplantation for chronic granulomatous disease.

Authors:  A Bhattacharya; M Slatter; A Curtis; C E Chapman; D Barge; A Jackson; T J Flood; M Abinun; A J Cant; A R Gennery
Journal:  Bone Marrow Transplant       Date:  2003-03       Impact factor: 5.483

Review 9.  Hematopoietic cell transplantation for correction of primary immunodeficiencies.

Authors:  Ah Filipovich
Journal:  Bone Marrow Transplant       Date:  2008-08       Impact factor: 5.483

10.  Hematopoietic stem cell transplantation from matched unrelated donors in chronic granulomatous disease.

Authors:  C Schuetz; M Hoenig; S Gatz; F Speth; U Benninghoff; A Schulz; K M Debatin; W Friedrich
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

View more
  2 in total

Review 1.  Chronic granulomatous disease: overview and hematopoietic stem cell transplantation.

Authors:  Elizabeth M Kang; Betty E Marciano; SukSee DeRavin; Kol A Zarember; Steven M Holland; Harry L Malech
Journal:  J Allergy Clin Immunol       Date:  2011-04-17       Impact factor: 10.793

2.  Myeloablative transplantation using either cord blood or bone marrow leads to immune recovery, high long-term donor chimerism and excellent survival in chronic granulomatous disease.

Authors:  Priti Tewari; Paul L Martin; Adam Mendizabal; Suhag H Parikh; Kristin M Page; Timothy A Driscoll; Harry L Malech; Joanne Kurtzberg; Vinod K Prasad
Journal:  Biol Blood Marrow Transplant       Date:  2012-02-10       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.